A cross‐cohort cognitive composite for tracking changes in pre‐clinical and prodromal Alzheimer’s disease


The primary goal of large global studies investigating Alzheimer’s Disease (AD) is to make meaningful and robust conclusions on cognitive outcomes. However, this is challenging due to the heterogeneous cognitive test batteries used across studies. Here, we use four international cohorts to derive robust and sensitive cross-cohort cognitive composites.